Hanmi Pharm launches Korea’s first modified drug for influenza, ‘Hanmi Flu’

Published: 2016-02-18 11:19:19

Updated: 2016-02-18 11:19:19

Hanmi Pharm(CEO Kwan-soon Lee, www.hanmi.co.kr) announced to launch Hanmi Flu, the Korea’s first incrementally modified drug for influenza on the 16^th.

The company stated Hanmi Flu(generic name: oseltamivir), a treatment having effects for influenza A & B, which acquired approval as an incrementally modified drug through the salt modification of Tamiflu, is expected to be launched in 3 volumes...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.